451 related articles for article (PubMed ID: 29389947)
41. Exome Sequencing for Prenatal Detection of Genetic Abnormalities in Fetal Ultrasound Anomalies: An Economic Evaluation.
Kodabuckus SS; Quinlan-Jones E; McMullan DJ; Maher ER; Hurles ME; Barton PM; Kilby MD
Fetal Diagn Ther; 2020; 47(7):554-564. PubMed ID: 31962312
[TBL] [Abstract][Full Text] [Related]
42. Utility of Whole Exome Sequencing for Genetic Diagnosis of Previously Undiagnosed Pediatric Neurology Patients.
Kuperberg M; Lev D; Blumkin L; Zerem A; Ginsberg M; Linder I; Carmi N; Kivity S; Lerman-Sagie T; Leshinsky-Silver E
J Child Neurol; 2016 Dec; 31(14):1534-1539. PubMed ID: 27572814
[TBL] [Abstract][Full Text] [Related]
43. Intersociety policy statement on the use of whole-exome sequencing in the critically ill newborn infant.
Borghesi A; Mencarelli MA; Memo L; Ferrero GB; Bartuli A; Genuardi M; Stronati M; Villani A; Renieri A; Corsello G;
Ital J Pediatr; 2017 Nov; 43(1):100. PubMed ID: 29100554
[TBL] [Abstract][Full Text] [Related]
44. A semiautomated whole-exome sequencing workflow leads to increased diagnostic yield and identification of novel candidate variants.
Ji J; Shen L; Bootwalla M; Quindipan C; Tatarinova T; Maglinte DT; Buckley J; Raca G; Saitta SC; Biegel JA; Gai X
Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30755392
[TBL] [Abstract][Full Text] [Related]
45. A single center experience with publicly funded clinical exome sequencing for neurodevelopmental disorders or multiple congenital anomalies.
Pode-Shakked B; Barel O; Singer A; Regev M; Poran H; Eliyahu A; Finezilber Y; Segev M; Berkenstadt M; Yonath H; Reznik-Wolf H; Gazit Y; Chorin O; Heimer G; Gabis LV; Tzadok M; Nissenkorn A; Bar-Yosef O; Zohar-Dayan E; Ben-Zeev B; Mor N; Kol N; Nayshool O; Shimshoviz N; Bar-Joseph I; Marek-Yagel D; Javasky E; Einy R; Gal M; Grinshpun-Cohen J; Shohat M; Dominissini D; Raas-Rothschild A; Rechavi G; Pras E; Greenbaum L
Sci Rep; 2021 Sep; 11(1):19099. PubMed ID: 34580403
[TBL] [Abstract][Full Text] [Related]
46. Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing.
Reuter CM; Kohler JN; Bonner D; Zastrow D; Fernandez L; Dries A; Marwaha S; Davidson J; Brokamp E; Herzog M; Hong J; Macnamara E; Rosenfeld JA; Schoch K; Spillmann R; ; Loscalzo J; Krier J; Stoler J; Sweetser D; Palmer CGS; Phillips JA; Shashi V; Adams DA; Yang Y; Ashley EA; Fisher PG; Mulvihill JJ; Bernstein JA; Wheeler MT
J Genet Couns; 2019 Dec; 28(6):1107-1118. PubMed ID: 31478310
[TBL] [Abstract][Full Text] [Related]
47. A population-based cost-effectiveness study of early genetic testing in severe epilepsies of infancy.
Howell KB; Eggers S; Dalziel K; Riseley J; Mandelstam S; Myers CT; McMahon JM; Schneider A; Carvill GL; Mefford HC; ; Scheffer IE; Harvey AS
Epilepsia; 2018 Jun; 59(6):1177-1187. PubMed ID: 29750358
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic exome sequencing in 100 consecutive patients with both epilepsy and intellectual disability.
Snoeijen-Schouwenaars FM; van Ool JS; Verhoeven JS; van Mierlo P; Braakman HMH; Smeets EE; Nicolai J; Schoots J; Teunissen MWA; Rouhl RPW; Tan IY; Yntema HG; Brunner HG; Pfundt R; Stegmann AP; Kamsteeg EJ; Schelhaas HJ; Willemsen MH
Epilepsia; 2019 Jan; 60(1):155-164. PubMed ID: 30525188
[TBL] [Abstract][Full Text] [Related]
49. Reduced resource utilization with early use of next-generation sequencing in rare genetic diseases in an Asian cohort.
Nazeha N; Koh AL; Kam S; Lim JY; Goh DLM; Jamuar SS; Graves N
Am J Med Genet A; 2022 Dec; 188(12):3482-3491. PubMed ID: 36156406
[TBL] [Abstract][Full Text] [Related]
50. [Exome diagnostics in neurology].
Zech M; Wagner M; Schormair B; Oexle K; Winkelmann J
Nervenarzt; 2019 Feb; 90(2):131-137. PubMed ID: 30645660
[TBL] [Abstract][Full Text] [Related]
51. Implementation of a genomic medicine multi-disciplinary team approach for rare disease in the clinical setting: a prospective exome sequencing case series.
Taylor J; Craft J; Blair E; Wordsworth S; Beeson D; Chandratre S; Cossins J; Lester T; Németh AH; Ormondroyd E; Patel SY; Pagnamenta AT; Taylor JC; Thomson KL; Watkins H; Wilkie AOM; Knight JC
Genome Med; 2019 Jul; 11(1):46. PubMed ID: 31345272
[TBL] [Abstract][Full Text] [Related]
52. Reducing diagnostic turnaround times of exome sequencing for families requiring timely diagnoses.
Bourchany A; Thauvin-Robinet C; Lehalle D; Bruel AL; Masurel-Paulet A; Jean N; Nambot S; Willems M; Lambert L; El Chehadeh-Djebbar S; Schaefer E; Jaquette A; St-Onge J; Poe C; Jouan T; Chevarin M; Callier P; Mosca-Boidron AL; Laurent N; Lefebvre M; Huet F; Houcinat N; Moutton S; Philippe C; Tran-Mau-Them F; Vitobello A; Kuentz P; Duffourd Y; Rivière JB; Thevenon J; Faivre L
Eur J Med Genet; 2017 Nov; 60(11):595-604. PubMed ID: 28807864
[TBL] [Abstract][Full Text] [Related]
53. The utility of next-generation sequencing technologies in diagnosis of Mendelian mitochondrial diseases and reflections on clinical spectrum.
Kose M; Isik E; Aykut A; Durmaz A; Kose E; Ersoy M; Diniz G; Adebali O; Ünalp A; Yilmaz Ü; Karaoğlu P; Edizer S; Tekin HG; Özdemir TR; Atik T; Onay H; Özkınay F
J Pediatr Endocrinol Metab; 2021 Apr; 34(4):417-430. PubMed ID: 33629572
[TBL] [Abstract][Full Text] [Related]
54. A head-to-head evaluation of the diagnostic efficacy and costs of trio versus singleton exome sequencing analysis.
Tan TY; Lunke S; Chong B; Phelan D; Fanjul-Fernandez M; Marum JE; Kumar VS; Stark Z; Yeung A; Brown NJ; Stutterd C; Delatycki MB; Sadedin S; Martyn M; Goranitis I; Thorne N; Gaff CL; White SM
Eur J Hum Genet; 2019 Dec; 27(12):1791-1799. PubMed ID: 31320747
[TBL] [Abstract][Full Text] [Related]
55. Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence.
Nurchis MC; Riccardi MT; Radio FC; Chillemi G; Bertini ES; Tartaglia M; Cicchetti A; Dallapiccola B; Damiani G
Health Policy; 2022 Apr; 126(4):337-345. PubMed ID: 35317923
[TBL] [Abstract][Full Text] [Related]
56. Real-world utility of whole exome sequencing with targeted gene analysis for focal epilepsy.
Perucca P; Scheffer IE; Harvey AS; James PA; Lunke S; Thorne N; Gaff C; Regan BM; Damiano JA; Hildebrand MS; Berkovic SF; O'Brien TJ; Kwan P
Epilepsy Res; 2017 Mar; 131():1-8. PubMed ID: 28199897
[TBL] [Abstract][Full Text] [Related]
57. Panel-Based Exome Sequencing for Neuromuscular Disorders as a Diagnostic Service.
Westra D; Schouten MI; Stunnenberg BC; Kusters B; Saris CGJ; Erasmus CE; van Engelen BG; Bulk S; Verschuuren-Bemelmans CC; Gerkes EH; de Geus C; van der Zwaag PA; Chan S; Chung B; Barge-Schaapveld DQCM; Kriek M; Sznajer Y; van Spaendonck-Zwarts K; van der Kooi AJ; Krause A; Schönewolf-Greulich B; de Die-Smulders C; Sallevelt SCEH; Krapels IPC; Rasmussen M; Maystadt I; Kievit AJA; Witting N; Pennings M; Meijer R; Gillissen C; Kamsteeg EJ; Voermans NC
J Neuromuscul Dis; 2019; 6(2):241-258. PubMed ID: 31127727
[TBL] [Abstract][Full Text] [Related]
58. Whole-Exome Sequencing Enables a Precision Medicine Approach for Kidney Transplant Recipients.
Mann N; Braun DA; Amann K; Tan W; Shril S; Connaughton DM; Nakayama M; Schneider R; Kitzler TM; van der Ven AT; Chen J; Ityel H; Vivante A; Majmundar AJ; Daga A; Warejko JK; Lovric S; Ashraf S; Jobst-Schwan T; Widmeier E; Hugo H; Mane SM; Spaneas L; Somers MJG; Ferguson MA; Traum AZ; Stein DR; Baum MA; Daouk GH; Lifton RP; Manzi S; Vakili K; Kim HB; Rodig NM; Hildebrandt F
J Am Soc Nephrol; 2019 Feb; 30(2):201-215. PubMed ID: 30655312
[TBL] [Abstract][Full Text] [Related]
59. Towards a Change in the Diagnostic Algorithm of Autism Spectrum Disorders: Evidence Supporting Whole Exome Sequencing as a First-Tier Test.
Arteche-López A; Gómez Rodríguez MJ; Sánchez Calvin MT; Quesada-Espinosa JF; Lezana Rosales JM; Palma Milla C; Gómez-Manjón I; Hidalgo Mayoral I; Pérez de la Fuente R; Díaz de Bustamante A; Darnaude MT; Gil-Fournier B; Ramiro León S; Ramos Gómez P; Sierra Tomillo O; Juárez Rufián A; Arranz Cano MI; Villares Alonso R; Morales-Pérez P; Segura-Tudela A; Camacho A; Nuñez N; Simón R; Moreno-García M; Alvarez-Mora MI
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33921431
[TBL] [Abstract][Full Text] [Related]
60. The clinical utility of whole-exome sequencing in the context of rare diseases - the changing tides of medical practice.
Nguyen MT; Charlebois K
Clin Genet; 2015 Oct; 88(4):313-9. PubMed ID: 25421945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
